NDC 62135-496
Griseofulvin MICROSIZE
Griseofulvin
Griseofulvin MICROSIZE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc.. The primary component is Griseofulvin.
| Product ID | 62135-496_e1015d4f-428a-4b66-b55b-aabc86d223d3 |
| NDC | 62135-496 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Griseofulvin MICROSIZE |
| Generic Name | Griseofulvin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1971-09-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA060569 |
| Labeler Name | Chartwell RX, LLC. |
| Substance Name | GRISEOFULVIN |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |